Catalyst Pharmaceuticals, Inc.

CPRX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$517,553$137,636$298,395$171,445
Short-Term Investments$0$0$0$19,821
Receivables$65,487$53,514$10,793$6,724
Inventory$19,541$15,644$6,805$7,870
Other Curr. Assets$21,028$12,535$4,813$4,246
Total Curr. Assets$623,609$219,329$320,806$210,106
Property Plant & Equip (Net)$3,584$3,703$3,617$3,976
Goodwill$0$0$0$0
Intangibles$156,672$194,049$32,471$0
Long-Term Investments$21,564$16,489$0$0
Tax Assets$45,982$36,544$18,736$23,697
Other NC Assets$0$0$0$9
Total NC Assets$227,802$250,785$54,824$27,682
Other Assets$0$0$0$0
Total Assets$851,411$470,114$375,630$237,788
Liabilities
Payables$16,593$14,795$3,975$2,768
Short-Term Debt$402$369$337$308
Tax Payable$894$729$8,702$79
Deferred Revenue$0$0$0$0
Other Curr. Liab.$102,789$60,170$44,574$23,908
Total Curr. Liab.$120,678$76,063$57,588$27,063
LT Debt$2,786$3,188$3,557$3,894
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$315$2,982$14,064$0
Total NC Liab.$3,101$6,170$17,621$3,894
Other Liabilities$0$0$0$0
Cap. Leases$3,188$3,557$3,894$4,202
Total Liabilities$123,779$82,233$75,209$30,957
Equity
Pref Stock$0$0$0$0
Common Stock$121$107$105$103
Retained Earnings$285,161$121,272$49,862-$26,310
AOCI$64$14$24-$148
Other Equity$442,286$266,488$250,430$233,186
Total Equity$727,632$387,881$300,421$206,831
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$851,411$470,114$375,630$237,788
Net Debt-$514,365-$134,079-$294,501-$167,243
Catalyst Pharmaceuticals, Inc. (CPRX) Financial Statements & Key Stats | AlphaPilot